Alerus Financial (FRA:5QD) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:5QD Alerus Financial Corp FRA:5QD
58 GF Score
Price €26.60
GF Value €18.10
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Alerus Financial Research & Development?

Alerus Financial FRA:5QD -2.92% 58 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:5QD with a GF Score™ of 58/100 and a GF Value™ of €18.10 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Alerus Financial's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Alerus Financial  (FRA:5QD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alerus Financial Research & Development Related Terms

Alerus Financial Research & Development Historical Data

* Premium members only.

The historical data trend for Alerus Financial's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alerus Financial Research & Development Chart

Alerus Financial Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alerus Financial Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:5QD
58GF Score
Alerus Financial Corp FRA:5QD
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alerus Financial Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Alerus Financial (FRA:5QD) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Alerus Financial and its competitors.
Is Alerus Financial's Research & Development too high?
Alerus Financial's current Research & Development is €0.0 Mil. Overall, Alerus Financial has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alerus Financial's Research & Development compare to FISI and SMBK?
Alerus Financial's Research & Development of €0.0 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Alerus Financial and its competitors. Alerus Financial's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alerus Financial stock overvalued right now?
Based on GuruFocus' analysis, Alerus Financial (FRA:5QD) is currently considered Significantly Overvalued. The stock's GF Value™ is €18.10, compared to a current price of €26.60 — trading 47% above its estimated fair value. The current Research & Development is €0.0 Mil. Alerus Financial's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Alerus Financial (FRA:5QD), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alerus Financial (FRA:5QD) Overvalued in 2026?

Based on GuruFocus' analysis, Alerus Financial stock appears to be overvalued. The current stock price of €26.60 is trading 47% above its estimated GF Value™ of €18.10. GuruFocus considers Alerus Financial to be Significantly Overvalued.

Key valuation signals for FRA:5QD:

  • Research & Development: €0.0 Mil
  • GF Value™: €18.10 vs. price of €26.60 (47% above fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the FRA:5QD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alerus Financial Business Description

Other Exchanges ALRS:USA
Address 401 Demers Avenue, Grand Forks, ND, USA, 58201
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and others. The company provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services and wealth management services, including retirement plans, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.
58GF Score

Get the complete analysis for FRA:5QD

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.60
Price
€18.10
GF Value